Cargando…

IDF21-0567 Analysis of mortality and cardio-metabolic comorbidities in Covid-19 patients from Eastern European region

Detalles Bibliográficos
Autores principales:	Popescu, I., Bumgardner, C., Iancu, D., Mussman, G.M., Hughes, C.B., Fowlkes, J.L., Preda, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164796/ http://dx.doi.org/10.1016/j.diabres.2022.109380

Ejemplares similares

P05.67. A narrative review of research on Ayurveda
por: Manohar, R, et al.
Publicado: (2012)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

The Heroes of the I.D.F.
por: Gotweter, Y.
Publicado: (1967)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

Airflow Obstruction and Cardio-metabolic Comorbidities
por: Triest, Filip J.J., et al.
Publicado: (2019)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

IDF21-0363 Evaluation of virtual consultation and patient satisfaction during COVID-19 – Survey at the Chronic Care Center, Lebanon
por: Rayes Sadek, C., et al.
Publicado: (2022)

IDF21-0542 Sharing “a.ma.dia” Experiences of how the Institution Have Faced COVID-19 Issues
por: Ramamonjisoa, H.A., et al.
Publicado: (2022)

IDF21-0194 Impact of COVID-19 during period of Level 3 alert on access to diabetes care in central Taiwan
por: Yang, Y.S., et al.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis
por: Juangco, J.R., et al.
Publicado: (2022)

IDF21-0521 Peer Support for Diabetes Management in the Shanghai Integration Model Developed Community Capacity to Combat COVID-19
por: Liu, Y., et al.
Publicado: (2022)

IDF21-0510 Human Serum Metabolites as Potential Mediators from Obesity to COVID-19: A Network Mendelian Randomization Study
por: Huang, C., et al.
Publicado: (2022)

IDF21-0175 Experiences of delivering virtual education workshops for children with type 1 diabetes during the Covid-19 pandemic
por: Chan, P.L.C., et al.
Publicado: (2022)

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022)

IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19
por: Inamdar, A., et al.
Publicado: (2022)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

IDF21-0080 Determinants of acceptability to COVID-19 vaccine among the general public and diabetes population in Israel
por: Kolobov, T., et al.
Publicado: (2022)

IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes
por: Munda, A., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects
por: Baidya, A., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0636 Effects of COVID-19 lockdown on lifestyle changes and medical challenges in patients with type 1 diabetes in south India
por: Guha Pradeepa, R.P., et al.
Publicado: (2022)

IDF2022-0579 Post COVID-19 diabetes project: Intensive cardio-renal-metabolic management for people living with type 2 diabetes (T2D)
por: Ahmad, E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2hhvoa2b3i8od7gj92e1igu1m